Cargando…
T Cell Therapy for Nasopharyngeal Carcinoma
Among the novel biologic therapeutics that will increase our ability to cure human cancer in the years to come, T cell therapy is one of the most promising approaches. However, with the possible exception of tumor-infiltrating lymphocytes therapy for melanoma, clinical trials of adoptive T-cell ther...
Autores principales: | Basso, S, Zecca, M, Merli, P, Gurrado, A, Secondino, S, Quartuccio, G, Guido, I, Guerini, P, Ottonello, G, Zavras, N, Maccario, R, Pedrazzoli, P, Comoli, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119400/ https://www.ncbi.nlm.nih.gov/pubmed/21716854 |
Ejemplares similares
-
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma
por: Secondino, Simona, et al.
Publicado: (2023) -
Immunotherapeutic Intervention against Sarcomas
por: Pedrazzoli, Paolo, et al.
Publicado: (2011) -
Clinical Trials of Cellular Therapies in Solid Tumors
por: Secondino, Simona, et al.
Publicado: (2023) -
Persistent rhinovirus infection in pediatric hematopoietic stem cell transplant recipients with impaired cellular immunity
por: Piralla, Antonio, et al.
Publicado: (2015) -
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
por: Cioni, Michela, et al.
Publicado: (2017)